Search
News
Conducting after-action reviews of the public health response to COVID-19
ECDC has published an updated guidance on designing and conducting after-action reviews (AARs) of the public health response to the COVID-19 pandemic.
News
Weekly COVID-19 country overview
This weekly report provides an overview of the epidemiological situation of the COVID-19 pandemic and COVID-19 vaccine rollout by country.
Data
Data on testing for COVID-19 by week and country
Data in multiple file formats with information about testing volume for COVID-19, sorted by week and country, and updated on a weekly basis.
Data
Data on hospital and ICU admission rates and current occupancy for COVID-19
Data in multiple file formats with information about hospitalisation and Intensive Care Unit (ICU) admission rates and current occupancy for COVID-19, sorted by date and country.
Data
Data on 14-day notification rate of new COVID-19 cases and deaths
Data in various file formats on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population and 14-day notification rate of reported deaths per million population by week and country, in the EU/EEA and the UK.
Data
Data on the 14-day age-specific notification rate of new COVID-19 cases
The downloadable data file contains information on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population by age group, week and country.
Scientific and technical publications
Conducting after-action reviews of the public health response to COVID-19: update
This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.
News
Regional workshop on COVID-19 recovery in Tunisia
The workshop organised by ECDC took place from 7 - 9 March in Tunis, upon invitation of the Tunisian National Observatory of New and Emerging Diseases (NONED).
Scientific and technical publications
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – fourth update
This update reports on one of the ECDC multi-country studies that is centred around the hospital setting and severe disease, with the aim of assessing vaccine effectiveness against severe acuterespiratory infection (SARI) due to laboratory-confirmed SARS-CoV-2 within the ECDC VaccineEffectiveness, Burden and Impact Studies infrastructure (VEBIS) [1,2].
Data
Data on COVID-19 vaccination in the EU/EEA
Data in various file formats with information on COVID-19 vaccine doses administered, manufacturers, and target groups in the EU/EEA.